On Monday, Shares of Ares Capital Corporation (NASDAQ:ARCC), subtract -0.52% and closed at $15.16 in the last trading session. ARCC stock opened its last trade at $15.20 and after floating in a range of $15.16 to $15.31. The company’s Market capitalization is $4.72 Billion with the total Outstanding Shares of 313.95 million. During the 52-week trading session the minimum price at which share price traded, registered at $12.31 and reached to max level of $16.43. Ares Capital Corporation (“Ares Capital”) (ARCC) declared recently that it will report earnings for the third quarter ended September 30, 2016 on Wednesday, November 2, 2016 before the opening of the Nasdaq Global Select Market. Ares Capital Corporation invites all interested persons to attend its webcast/conference call at 12:00 p.m. (Eastern Time) on the same day to discuss its third quarter 2016 financial results.
Please visit the website to test your connection before the webcast. Domestic callers can access the conference call by dialing (888) 317-6003. International callers can access the conference call by dialing +1 (412) 317-6061. All callers will need to enter the Participant Elite Entry Number 2618707 followed by the # sign and reference “Ares Capital Corporation” once connected with the operator. All callers are asked to dial in 10-15 minutes before the call so that name and company information can be collected. For interested parties, an archived replay of the call will be available about one hour after the end of the call through November 15, 2016 at 5:00 p.m. (Eastern Time) to domestic callers by dialing (877) 344-7529 and to international callers by dialing +1 (412) 317-0088. For all replays, please reference conference number 10093115. An archived replay will also be available on a webcast link located on the Home page of the Shareholder Resources section of Ares Capital’s website.
Cempra Inc (NASDAQ:CEMP), jumped 1.16% and closed at $21.87 in the last trading session. CEMP stock opened its last trade at $21.52 and after floating in a range of $21.10 to $21.95. The company’s Market capitalization is $1.11 Billion with the total Outstanding Shares of 51.99 million. During the 52-week trading session the minimum price at which share price traded, registered at $14.03 and reached to max level of $34.24. Cempra, Inc. (CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, recently declared the presentation of three abstracts based upon analyzing treatment failures with existing antibiotics from more than 400,000 records of patients diagnosed with community-attained bacterial pneumonia (CABP) in a large U.S. insurance claims database.
The data analysis will be presented at the annual Academy of Managed Care Pharmacy Nexus meeting in National Harbor, MD from October 3-6, 2016.
These patient records were analyzed to assess rates of failure to the most commonly prescribed antibiotics to treat CABP. Treatment failure was defined as antibiotic prescription refill, new antibiotic claim, emergency room visit, or hospitalization occurring within 30 days of initial therapy.
This analysis showed that more than one out of five adult CABP patients failed initial antibiotic monotherapy, with the failure rate surpassing one out of four for an elderly population with certain comorbidities.